From the Journals

Resistant hypertension hits SLE patients hard


 

FROM ARTHRITIS CARE & RESEARCH

Patients with systemic lupus erythematosus (SLE) were 72% more likely to have resistant hypertension than were control patients at a tertiary care center.

wildpixel/Thinkstock

A patient with resistant hypertension either has blood pressure remaining above 140/90 mm Hg while taking three antihypertensive medications or requires the use of four or more antihypertensives to attain blood pressure control. Resistant hypertension, which was more likely to occur among blacks and patients with lower renal function, hypercholesterolemia, and increased inflammatory markers, increased the risk of death nearly threefold (hazard ratio, 2.91; P = .0005) when compared with those who didn’t have this condition.


The results of this analysis were published March 15 in Arthritis Care & Research (doi: 10.1002/acr.23880). We covered this study at the 2018 annual meeting of the American College of Rheumatology in Chicago before it was published in the journal. Read our previous story at the link above.

Recommended Reading

Aspirin appears underused to prevent preeclampsia in SLE patients
Clinician Reviews
Four distinct IgG4-related disease groups described in study
Clinician Reviews
Primary Sjögren’s syndrome: New research and new resources improve outlook
Clinician Reviews
New SLE disease activity measure beats SLEDAI-2K
Clinician Reviews
New findings raise questions about the role of ANAs in SLE
Clinician Reviews
Ehlers-Danlos syndrome: Increased IUGR risk reported
Clinician Reviews
List of medications linked to drug-induced lupus expands
Clinician Reviews
Vagus nerve stimulation for rheumatology? Maybe
Clinician Reviews
Myositis mimics: Clues for making the right diagnosis
Clinician Reviews
BTK inhibitor calms pemphigus vulgaris with low-dose steroids
Clinician Reviews